THX-B

• CAT Number: I042933
• CAS Number: 1372206-64-8
• Molecular Formula: C16H24N6O4
• Molecular Weight: 364.40
• Purity: ≥95%
• Synonyms: 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-propan-2-yl-N-(propan-2-ylcarbamoyl)acetamide
• InChI: InChI=1S/C16H24N6O4/c1-9(2)18-15(25)22(10(3)4)11(23)7-21-8-17-13-12(21)14(24)20(6)16(26)19(13)5/h8-10H,7H2,1-6H3,(H,18,25)
• InChIKey: NDUQXXCBPZEHEN-UHFFFAOYSA-N
• SMILES: CC(C)NC(=O)N(C(C)C)C(=O)CN1C=NC2=C1C(=O)N(C(=O)N2C)C

THX-B（Cat No.:I042933）is a novel small molecule compound that acts as a potent inhibitor targeting specific enzymes involved in cellular signaling and growth. It has shown promise in preclinical studies for its ability to modulate key pathways related to cancer, inflammation, and immune responses. THX-B works by interfering with the activity of proteins that regulate cell survival and proliferation, making it a potential therapeutic candidate for conditions such as cancer and autoimmune diseases. Researchers are investigating its efficacy in targeted therapies, aiming to improve treatment outcomes in various disease contexts.